Foundayo™ and dental problems

What the Foundayo™ documents cover

Foundayo™ is a once-daily orforglipron tablet approved in the US for weight management ^[1]. Its Prescribing Information and Medication Guide contain no dental side effect ^[1][2]. The entries that come closest are stomach reactions in Table 1, the pooled 72-week weight trials, and a warning about sedation ^[1]. Europe’s medicines committee gave a positive opinion in October 2026, but no EMA product information exists yet, and Health Canada has no Foundayo™ entry, so there is no other official list to check ^[9][10].

Dental entries in the trial registries

The two weight trials behind the label, ATTAIN-1 and ATTAIN-2, posted non-serious events only above 5% of a group; no dental term crossed that line, and no dental event was listed as serious ^[3][4]. Five smaller trials posted every event, so the dental picture there is more complete ^{[5][6][7][8][12]}. Each cell counts entries, not people: one person could have gingivitis and periodontitis recorded separately.

What these small numbers suggest

• In the three double-blind trials, decay and gum entries on orforglipron were similar to, or fewer than, those on placebo ^[5][6][8].
• ACHIEVE-J recorded four cavities on each of the two higher doses and one on the lowest, which looks like a gradient; that trial had no comparison group, was open label and lasted a year, so routine check-ups alone could explain it ^[12].
• Gum entries such as gingivitis and periodontitis were spread across every type of group, including dapagliflozin ^[7].
• None of these trials examined teeth systematically; entries depended on what people reported or dentists happened to find.

How a GLP-1 medicine could affect teeth

Supported by the label: acid exposure. Vomiting and reflux were more frequent on Foundayo™, especially while the dose was being raised ^[1]. NIDCR explains that acid makes enamel lose minerals, and that saliva and fluoride help it repair ^[13].

Suggested, not shown: less saliva. A 2026 review of GLP-1 medicines describes reports of dry mouth and reduced saliva and proposes dehydration after stomach side effects as one mechanism. It also says that reduced saliva combined with acid from reflux or vomiting may raise the risk of erosion, but that a direct link with these medicines has not been established ^[11]. The review did not include orforglipron, and no orforglipron study measured saliva.

Eating patterns: the label says Foundayo™ lowers food intake through reduced appetite ^[1]. NIDCR links frequent sugary or starchy snacks and drinks to decay ^[13], so the content of smaller meals matters more for teeth than their size.

Causes that matter more for most people

• Plaque that is not removed by daily brushing and flossing, which NIDCR names as the usual cause of gum disease ^[14].
• Smoking or other tobacco use, the most significant risk factor for gum disease ^[14].
• Diabetes, especially when blood sugar is not well controlled, which raises the chance of gum disease, dry mouth and thrush ^[15].
• Obesity, stress, older age, genetics and hormonal changes in women, all associated with gum disease ^[14].
• Frequent sugary drinks and snacks, and receding gums that expose tooth roots to decay ^[13].

Dental visits while taking Foundayo™

Most dental care uses local anaesthetic only. The label’s concern is procedures needing general anaesthesia or deep sedation: Foundayo™ slows stomach emptying, and rare reports with GLP-1 medicines describe stomach contents entering the lungs despite fasting ^[1]. The label says the data are not enough to recommend a different fasting time or a pause in treatment, and it asks you to tell providers before a planned procedure ^[1][2]. That includes the dentist or oral surgeon.

If you have type 2 diabetes, NIDCR asks you to tell your dentist about it ^[15]. Foundayo™ lowers blood glucose, and in a trial of adults with type 2 diabetes low blood sugar was more frequent on the tablet than on placebo, especially with a sulfonylurea ^[1]. A long fast before a dental appointment is worth discussing with the prescriber for that reason.

Protecting teeth: NIH guidance

NIDCR suggests brushing twice a day with fluoride toothpaste, cleaning between the teeth with floss or another interdental cleaner, limiting sugary drinks and foods high in sugars and starches, not using tobacco and seeing a dentist for regular check-ups and cleanings ^[13][14]. Early decay can be stopped or even reversed with fluoride before a cavity forms ^[13].

For the stomach side, the Foundayo™ Medication Guide asks you to tell your provider about stomach problems that are severe or do not go away ^[2]. Foundayo™ is raised no sooner than every 30 days, and the label reports vomiting most often during that escalation period ^[1].

Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.

When to get help